论文部分内容阅读
因有报告利福平可抑制细胞免疫,故作者选择健康对照20人,肺结核病29例(其中18例接受利福平治疗),以检查治疗剂量的利福平对循环中T和B淋巴细胞的作用。结果利福平治疗的18例中有8例(其中7例)用药时间超过6周,其T-淋巴细胞玫瑰花结明显受抑制,B细胞则不受抑制。健康对照组和未用
Because of reports of rifampicin can inhibit cellular immunity, so the author chose 20 healthy controls, pulmonary tuberculosis in 29 cases (18 cases of rifampicin treatment), to check the therapeutic dose of rifampin on circulating T and B lymphocytes Role. Results Of the 18 cases of rifampicin treatment, 8 cases (7 of them) were treated for more than 6 weeks, the rosette of T-lymphocytes was obviously inhibited and the B cells were not inhibited. Healthy control group and unused